… as a pT1 or pT3 tumor. Objective: We correlated the BRAF V600E mutation with both clinical-…
The vast majority of thyroid cancers are papillary thyroid carcinomas (PTCs), which account …

… Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.
Journal of Clinical Oncology 2015 33 42–50. (https://doi.org/10.1200/JCO.2014.56.8253) …

… BRAF V600E is detected in about half of PTC cases, … thyroid carcinoma, BRAF V600E
mutation has been shown to be associated with high risk clinicopathological characteristics, tumor …

… The prognostic value of the BRAFV600E mutation, resulting in poor clinical outcomes of
papillary thyroid carcinoma, has been generally confirmed. However, the association of …

… analysis we used the BRAF V600E mutation-specific antibody … peptide representing the
BRAF V600E-mutated amino-acid … Lymph node cells of anti-BRAF V600E-seropositive mice …

… BRAF mutations may occur in papillary thyroid carcinoma and also have … of BRAF V600E
mutation in the progression of PTMCS patients. Our results showed that BRAF V600E mutation …

… , which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas
a prognostic … However, the BRAF V600E mutation as a prognostic marker in papillary thyroid …

… mutation in papillary thyroid carcinoma (PTC). However, there have been conflicting data on
the usefulness of BRAF mutation as … mutation and the associations between BRAF mutation …

… meta-analysis to evaluate the associations between the BRAF V600E mutation status and
aggressive clinicopathological features and poor prognostic factors in papillary thyroid cancer. …

… BRAF V600E mutation represents the most common oncogenic event in sporadic papillary
thyroid cancer (PTC… Moreover, the impact of BRAF V600E mutants on tumour-related patient's …